Image

Global Womens Health Diagnostics Market - Industry Trends and Forecast to 2029

  • Semiconductors and Electronics
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Semiconductors and Electronics
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Womens Health Diagnostics Market, By Diagnostic Devices (Imaging and Monitoring Systems, Biopsy Devices, Reagents and Kits, Biomarkers, Others), Application (Osteoporosis Testing, OVC Testing, Cervical Cancer Testing, Breast Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Infectious Disease Testing, STD Testing, Ultrasound Tests), End User (Hospitals, Diagnostic and Imaging Centers, Clinics, Home Care Setting)-Industry Trends and Forecast to 2029.

Womens Health Diagnostics Market

Global Womens Health Diagnostics Market Analysis and Size

Biopsy, ultrasonography, chemotherapy, and magnetic resonance imaging are among the modern laboratory tests, techniques, and treatments used in women's health diagnosis. Several healthcare diagnostics institutes are now offering a wide range of laboratory testing solutions to help with the diagnosis and management of rare diseases and ailments affecting women.

  • Breast cancer testing segment accounted for the larger market share due to the breast cancer is becoming more common, and people are becoming more aware of advanced breast cancer detection techniques such as ABUS. Data Bridge Market Research analyses that the womens health diagnostics market is expected to grow at a CAGR of 8.4% during the forecast period of 2022 to 2029, at a USD 27.10 billion in 2021 and is further estimated to reach USD 51.67 billion by 2029.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Diagnostic Devices (Imaging and Monitoring Systems, Biopsy Devices, Reagents and Kits, Biomarkers, Others), Application (Osteoporosis Testing, OVC Testing, Cervical Cancer Testing, Breast Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Infectious Disease Testing, STD Testing, Ultrasound Tests), End User (Hospitals, Diagnostic and Imaging Centers, Clinics, Home Care Setting)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Siemens (Germany), Hologic, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (US), BD (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific (US), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp. (US), Shimadzu Corporation (Japan), bioMérieux SA (France), Carestream Health (US), MEDGYN PRODUCTS, INC. (US), URIT MEDICAL ELECTRONIC CO., LTD (China), COOK (US), Cardinal Health (US), PerkinElmer Inc. (US), General Electric Company (US), Quest Diagnostics Incorporated (US), Danaher (US), Sysmex Corporation (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan), FUJIFILM Holdings Corporation (Japan).

Market Opportunities

  • Rising frequency of chronic and lifestyle-related disorders
  • The growing number of imaging and diagnostic facilities
  • The increased adoption of point-of-care and quick diagnostic tests
  • Collaborations and partnerships

Global Womens Health Diagnostics Market Definition

The diagnosis and treatment of problems and diseases that may impair the physical and mental health of women is referred to as women's health diagnostics. Gynecology disorders, breast cancer, ovarian cancer, birth control, sexually transmitted infections (STIs), female cancers, menopause, hormone therapy, pregnancy and childbirth, sexual health, osteoporosis, heart disease, and benign conditions that may affect the functions of a female body are among the specialties and focus areas of the field.

Womens Health Diagnostics Market Dynamics

Drivers

Major factors that are expected to boost the growth of the womens health diagnostics market in the forecast period are as follows:

Drivers

  • Rise in the incidence of infectious diseases in women

The majority of sexually transmitted illnesses can be dangerously transmitted to a foetus or infant. In the United States, STDs are responsible for more than half of all cases of avoidable infertility will further accelerate the growth of the market.

  • Growing adoption of point-of-care and rapid diagnostic tests

POC tests, for example, are frequently used to detect HIV in patients. Infectious disorders such as HIV, UTIs, and tuberculosis can be better managed with rapid POC tests, especially in developing countries where prompt medical care is scarce is further anticipated to propel the growth of the market.

  • Increase in the geriatric population

Because older people have decreased physiological functions, impaired blood circulation, and are more prone to chronic diseases, the expansion in the geriatric pool supports market growth.

Opportunities

In addition, the enhancing healthcare infrastructure is further estimated to provide potential opportunities for the growth of the womens health diagnostics market in the coming years.

Restraints/Challenges Global Womens Health Diagnostics Market

On the other hand, the increased cost of diagnostic imaging systems and procedures is further projected to impede the growth of the womens health diagnostics market in the targeted period. However, the strict regulatory guidelines might further challenge the growth of the womens health diagnostics market in the near future.

This womens health diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the womens health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Womens Health Diagnostics Market

The pandemic of COVID-19 has had a huge impact on the womens health diagnostics market. To contain the coronavirus (COVID-19) outbreak, countries closed their borders and hampered transportation and travel, impeding international trade and transportation. The supply chains for women's health diagnostics were interrupted, resulting in a temporary drop in demand due to global economic and capital market instability. However, in the post-COVID scenario, womens health diagnostics market is projected to be significantly impacted.

Recent Development

  • In September 2021, Terumo Aortic had announced the start of PANTHER, the company's global surgical transplant research. This prospective and retrospective multi-center, multi-arm post-market study looks at the company's whole line of knitted and woven surgical grafts and cardiovascular patches.

Global Womens Health Diagnostics Market Scope and Market Size

The womens health diagnostics market is segmented on the basis of material, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnostic Devices

  • Imaging and Monitoring Systems
  • Biopsy Devices
  • Reagents and Kits
  • Biomarkers
  • Others

On the basis of diagnostic devices, the womens health diagnostics market is segmented into imaging and monitoring systems, biopsy devices, reagents and kits, biomarkers and others.

Application

  • Osteoporosis Testing
  • OVC Testing
  • Cervical Cancer Testing
  • Breast Cancer Testing
  • Pregnancy and Fertility Testing
  • Prenatal Genetic Screening and Carrier Testing
  • Infectious Disease Testing
  • STD Testing
  • Ultrasound Tests

On the basis of application, the womens health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy and fertility testing, prenatal genetic screening and carrier testing, infectious disease testing, STD testing and ultrasound tests. Osteoporosis testing is further sub segmented into bone densitometry and in vitro blood tests. OVC testing is further sub segmented into OVC tumor marker tests, OVC diagnostic imaging tests and other OVC tests. Cervical cancer testing is further sub segmented into pap smears and HPV testing. Breast cancer testing is further sub segmented into mammography, breast cancer tumor marker tests, biopsies and other breast cancer tests. Pregnancy and fertility testing is further sub segmented into lab-based testing, pregnancy testing and ovulation prediction kits and fertility monitors. Prenatal genetic screening and carrier testing is further sub segmented into CF testing, Down’s syndrome and Edwards’ syndrome testing, torch testing and other prenatal genetic disease tests. Infectious disease testing is further sub segmented into MRSA testing, UTI testing, hepatitis testing, tuberculosis testing and other infectious disease tests. STD testing is further sub segmented into CT/NG testing, HIV testing and other STD Tests. Ultrasound tests is further sub segmented into breast imaging and OB/GYN imaging.

End user                                                                                        

  • Hospitals
  • Diagnostic and Imaging Centers
  • Clinics
  • Home Care Setting

On the basis of end user, the womens health diagnostics market is segmented into spitals, diagnostic and imaging centers, clinics and home care setting.

Womens Health Diagnostics Market Regional Analysis/Insights

The womens health diagnostics market is analysed and market size insights and trends are provided by country, material, application and end user as referenced above.

The countries covered in the womens health diagnostics market report are U.S., Canada, and Mexico in North America, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC)  in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).

North America dominates the womens health diagnostics market due to the rise in the adoption of technologically advanced products. Furthermore, the initiatives taken by the government and product launches will further boost the growth of the womens health diagnostics market in the region during the forecast period.

Asia-Pacific is further projected to observe significant amount of growth in the womens health diagnostics market due to the improving healthcare infrastructure. Moreover, the initiatives taken by the government and increase in the participation of women in workforce. Moreover, the rise in the awareness regarding women’s health disorders is further anticipated to propel the growth of the womens health diagnostics market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The womens health diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for womens health diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the womens health diagnostics market. The data is available for historic period 2010-2020.

Competitive Landscape and Womens Health Diagnostics Market Share Analysis

The womens health diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to womens health diagnostics market.

 Some of the major players operating in the womens health diagnostics market are:

  • Siemens (Germany)
  • Hologic, Inc. (US)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Abbott (US)
  • BD (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Thermo Fisher Scientific (US)
  • Koninklijke Philips N.V. (Netherlands)
  • NeuroLogica Corp. (US)
  • Shimadzu Corporation (Japan)
  • bioMérieux SA (France)
  • Carestream Health (US)
  • MEDGYN PRODUCTS, INC. (US)
  • URIT MEDICAL ELECTRONIC CO., LTD (China)
  • COOK (US)
  • Cardinal Health (US)
  • PerkinElmer Inc. (US)
  • General Electric Company (US)
  • Quest Diagnostics Incorporated (US)
  • Danaher (US)
  • Sysmex Corporation (Japan)
  • Hitachi, Ltd. (Japan)
  • Canon Inc. (Japan)
  • FUJIFILM Holdings Corporation (Japan)

Research Methodology : Global Womens Health Diagnostics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-womens-health-diagnostics-market


SKU-
Why Choose Us


Frequently Asked Questions

The Market Value for Womens Health Diagnostics Market is expected USD 51.67 billion by 2029.
The Womens Health Diagnostics Market is to Grow at a CAGR of 8.4% During the Forecast Period of 2022 to 2029.
Siemens (Germany), Hologic, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (US), BD (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific (US), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp. (US), Shimadzu Corporation (Japan), bioMérieux SA (France), Carestream Health (US), MEDGYN PRODUCTS, INC. (US), URIT MEDICAL ELECTRONIC CO., LTD (China), COOK (US), Cardinal Health (US), PerkinElmer Inc. (US), General Electric Company (US), Quest Diagnostics Incorporated (US), Danaher (US), Sysmex Corporation (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan), FUJIFILM Holdings Corporation (Japan) are the Major Companies Operating in the Womens Health Diagnostics Market.
The Countries Covered in the Womens Health Diagnostics Market Report are U.S., Canada, and Mexico in North America, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).
The Womens Health Diagnostics Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.